Could you imagine an end to the need for daily insulin injections for type 1 diabetes patients? There is hope that this could become a reality thanks to Dr Kisha Sivanathan’s research, focusing on a potential therapy that could see the end of daily injections and insulin pumps for patients
With the support of a recent $50,000 grant from Kidney, Transplant & Diabetes Research Australia (KTDRA) Dr Shilpa Jesudason and the CNARTS Clinical Research Group are implementing a patient centred research project focused on improving outcomes for people living with chronic kidney disease.
Working closely with chronic kidney disease and diabetes sufferers on a daily basis, dietitian Anthony Meade is driven to help these patients have the best treatment experience they can informed by the latest nutritional research.
Islet transplantation is revolutionising treatment for type 1 diabetes and other chronic conditions like pancreatitis, changing the lives of those living with the debilitating conditions.
Kidney, Transplant & Diabetes Research Australia (KTDRA) in partnership with The Hospital Research Foundation (THRF) is thrilled to direct $330,000 to ensure six more pancreatic islet auto-transplants can take place at the Royal Adelaide Hospital (RAH), saving the lives of people living with severe and hereditary pancreatitis.
Nephrologist Dr Phil Clayton from the Royal Adelaide Hospital is passionate about continuing to advance medical research in kidney transplantation.
Sadly when people living with end stage kidney disease begin to lose the complete function of their kidneys, there are only three avenues of treatment ahead of them.
Kidney, Transplant and Diabetes Research Australia (KTDRA) is a disease specific affiliate of The Hospital Research Foundation (THRF).
One in three Australians are at risk of being diagnosed with chronic kidney disease in their lifetime.